Gallbladder cancer

JC Roa, P García, VK Kapoor, SK Maithel… - Nature reviews Disease …, 2022 - nature.com
Gallbladder cancer (GBC) is the most common cancer of the biliary tract, characterized by a
very poor prognosis when diagnosed at advanced stages owing to its aggressive behaviour …

Gastrointestinal cancers in China, the USA, and Europe

Y Xie, L Shi, X He, Y Luo - Gastroenterology report, 2021 - academic.oup.com
Gastrointestinal (GI) cancers, including colorectal cancer, gastric cancer, and esophageal
cancer, are a major medical and economic burden worldwide and have the largest number …

First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma …

YY Janjigian, K Shitara, M Moehler, M Garrido… - The Lancet, 2021 - thelancet.com
Background First-line chemotherapy for advanced or metastatic human epidermal growth
factor receptor 2 (HER2)-negative gastric or gastro-oesophageal junction adenocarcinoma …

Necroptosis‐related lncRNAs: predicting prognosis and the distinction between the cold and hot tumors in gastric cancer

Z Zhao, H Liu, X Zhou, D Fang, X Ou, J Ye… - Journal of …, 2021 - Wiley Online Library
Background. In the face of poor prognosis and immunotherapy failure of gastric cancer (GC),
this project tried to find new potential biomarkers for predicting prognosis and precision …

The immune microenvironment in gastric adenocarcinoma

Y Zavros, JL Merchant - Nature Reviews Gastroenterology & …, 2022 - nature.com
Like most solid tumours, the microenvironment of epithelial-derived gastric adenocarcinoma
(GAC) consists of a variety of stromal cell types, including fibroblasts, and neuronal …

Recent progress and future perspectives of immunotherapy in advanced gastric cancer

X Jin, Z Liu, D Yang, K Yin, X Chang - Frontiers in immunology, 2022 - frontiersin.org
As one of the most common forms of solid tumours, gastric carcinoma has been revealed as
the third leading cause of death worldwide. The symptom of gastric cancer is usually not …

Fibroblast growth factor receptors as treatment targets in clinical oncology

M Katoh - Nature reviews Clinical oncology, 2019 - nature.com
FGFRs are receptor tyrosine kinases with a role in several biological processes, such as the
regulation of development and tissue repair. However, alterations in FGFRs 1–4, such as …

Current status of immune checkpoint inhibitors for gastric cancer

K Kono, S Nakajima, K Mimura - Gastric cancer, 2020 - Springer
Recent breakthrough results from immune checkpoint inhibitors (ICI) have paved the way to
a new era of cancer immunotherapy. In particular, inhibition of programmed death-1 (PD …

USP14: structure, function, and target inhibition

F Wang, S Ning, B Yu, Y Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
Ubiquitin-specific protease 14 (USP14), a deubiquitinating enzyme (DUB), is associated
with proteasomes and exerts a dual function in regulating protein degradation. USP14 …

The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies

SK Daniel, YD Seo, VG Pillarisetty - Seminars in cancer biology, 2020 - Elsevier
Single agent checkpoint inhibitor therapy has not been effective for most gastrointestinal
solid tumors, but combination therapy with drugs targeting additional immunosuppressive …